Skip to main content
. 2023 Nov 9;15(11):2234. doi: 10.3390/v15112234

Figure 2.

Figure 2

A diagrammatic representation of the prodrug approach to improve TFV properties. TDF can improve pharmacokinetic properties, as it can cross the biological membrane. Enzymatic or chemical activation leads to a TFV form that is then converted to TFV-DP by the action of the kinases.